Systematic Financial Management LP Meridian Bioscience Inc Transaction History

Systematic Financial Management LP

$3.78 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	SELL	$31.15 - $33.39 $3.28 Million - $3.51 Million	-105,216 Reduced 14.05%	643,487 $21.4 Million
Q3 2022 Nov 14, 2022	BUY	$30.9 - $33.55 $262,804 - $285,342	8,505 Added 1.15%	748,703 $23.6 Million
Q2 2022 Aug 15, 2022	SELL	$23.75 - $31.69 $476,140 - $635,321	-20,048 Reduced 2.64%	740,198 $22.5 Million
Q1 2022 May 11, 2022	SELL	$19.97 - $26.94 $544,162 - $734,088	-27,249 Reduced 3.46%	760,246 $19.7 Million
Q4 2021 Feb 14, 2022	SELL	$17.46 - $21.61 $80,193 - $99,254	-4,593 Reduced 0.58%	787,495 $16.1 Million
Q3 2021 Nov 12, 2021	BUY	$17.35 - $22.5 $39,228 - $50,872	2,261 Added 0.29%	792,088 $15.2 Million
Q2 2021 Aug 12, 2021	BUY	$18.01 - $28.32 $1.24 Million - $1.94 Million	68,651 Added 9.52%	789,827 $17.5 Million
Q1 2021 May 10, 2021	SELL	$19.76 - $29.89 $333,311 - $504,184	-16,868 Reduced 2.29%	721,176 $18.9 Million
Q4 2020 Feb 12, 2021	BUY	$15.73 - $21.66 $65,562 - $90,278	4,168 Added 0.57%	738,044 $13.8 Million
Q3 2020 Nov 12, 2020	SELL	$13.54 - $26.41 $1.91 Million - $3.73 Million	-141,297 Reduced 16.15%	733,876 $12.5 Million
Q2 2020 Aug 13, 2020	SELL	$7.84 - $23.29 $2.87 Million - $8.52 Million	-366,012 Reduced 29.49%	875,173 $20.4 Million
Q1 2020 May 12, 2020	SELL	$5.57 - $11.5 $474,558 - $979,788	-85,199 Reduced 6.42%	1,241,185 $10.4 Million
Q4 2019 Feb 14, 2020	BUY	$7.9 - $10.14 $614,683 - $788,973	77,808 Added 6.23%	1,326,384 $13 Million
Q3 2019 Nov 06, 2019	BUY	$9.17 - $12.01 $507,907 - $665,209	55,388 Added 4.64%	1,248,576 $11.8 Million
Q2 2019 Jul 26, 2019	BUY	$10.88 - $17.6 $487,086 - $787,934	44,769 Added 3.9%	1,193,188 $14.2 Million
Q1 2019 May 03, 2019	SELL	$15.51 - $17.61 $38,433 - $43,637	-2,478 Reduced 0.22%	1,148,419 $20.2 Million
Q4 2018 Feb 13, 2019	BUY	$14.52 - $19.72 $152,067 - $206,527	10,473 Added 0.92%	1,150,897 $20 Million
Q3 2018 Nov 06, 2018	BUY	$14.85 - $16.35 $129,328 - $142,392	8,709 Added 0.77%	1,140,424 $17 Million
Q2 2018 Aug 08, 2018	BUY	$13.8 - $16.8 $1.58 Million - $1.93 Million	114,687 Added 11.28%	1,131,715 $18 Million
Q1 2018 May 09, 2018	BUY	$13.8 - $16.2 $1.78 Million - $2.09 Million	128,953 Added 14.52%	1,017,028 $14.4 Million
Q4 2017 Feb 09, 2018	BUY	$13.55 - $15.8 $10.7 Million - $12.5 Million	790,508 Added 810.22%	888,075 $12.4 Million
Q3 2017 Nov 08, 2017	BUY	$13.45 - $14.35 $1.31 Million - $1.4 Million	97,567	97,567 $1.4 Million

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Systematic Financial Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Systematic Financial Management LP with notifications on news.

Account